Please wait while we open this resource.
K
Clinical reviews
KETOACIDOSIS WITH SGLT2 INHIBITORS IN ROUTINE CLINICAL PRACTICE OF TYPE 2 DIABETES: SCANDINAVIAN COHORT AND NESTED CASE–CONTROL STUDY
Karolinska Institutet, Stockholm, Sweden
PDF202647 pages1.3 MB
The research focuses on the increased risk of ketoacidosis associated with SGLT2 inhibitors in type 2 diabetes patients. It utilizes a cohort and nested case–control study design, analyzing data from Denmark, Sweden, and Norway. The study includes a significant number of treatment episodes and aims to identify risk factors and outcomes related to ketoacidosis events during SGLT2 inhibitor therapy.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology